ProShare Advisors
IMUX icon

ProShare Advisors’s Immunic IMUX Stock Holding History

ProShare Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-52
Closed -$6K – 1633
2018
Q3 		$6K Sell
52
-3
-5% -$7.83K ﹤0.01% 1764
2018
Q2 		$149K Buy
55
+6
+12% +$13.9K ﹤0.01% 1673
2018
Q1 		$133K Sell
49
-8
-14% -$18.4K ﹤0.01% 1604
2017
Q4 		$135K Buy
+57
New +$126K ﹤0.01% 1706
2016
Q4 		– Sell
-56
Closed -$136K – 1745
2016
Q3 		$136K Sell
56
-9
-14% -$22.2K ﹤0.01% 1394
2016
Q2 		$162K Buy
65
+2
+3% +$6.57K ﹤0.01% 1464
2016
Q1 		$228K Sell
63
-6
-9% -$20.8K ﹤0.01% 1346
2015
Q4 		$318K Buy
+69
New +$225K ﹤0.01% 1263

Other funds holding IMUX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

ProShare Advisors's IMUX Position: Q4 2018 in Review

ProShare Advisors sold out of Immunic (IMUX) in Q4 2018, closing a stake of 52 shares — an estimated $6K sold.

ProShare Advisors first reported a position in IMUX in Q4 2015 and held it in 8 quarters. The position peaked at $318K in Q4 2015. 47 funds tracked by Wall St. Rank hold IMUX as of Q4 2018.

  • ProShare Advisors reported no remaining Immunic position as of Q4 2018 after selling out during the quarter.
  • ProShare Advisors sold 52 Immunic shares in Q4 2018, an estimated $6K.
  • ProShare Advisors first reported a position in Immunic in Q4 2015 and held it in 8 quarters.
  • ProShare Advisors's Immunic position peaked at $318K in Q4 2015.
  • 47 funds tracked by Wall St. Rank held Immunic as of Q4 2018.

Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.